ArticleFrontiers in public health2026
Explainable AI for early developmental disability detection: a neuro-fuzzy approach.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Developmental disabilities affect approximately 1 in 6 children aged 3-17 years. The diagnostic process typically spans 2-3 years and disproportionately affects underserved populations. Traditional machine learning approaches for screening have demonstrated promising accuracy but often lack the transparency required for clinical acceptance. Methods: We developed and validated an Adaptive Neuro-Fuzzy Inference System (ANFIS) using a longitudinal observational dataset of 5,000 children aged 1-6 years from 12 early childhood centers (4,311 typically developing; 689 with developmental disabilities, prevalence 13.8%). The ANFIS model implemented Gaussian membership functions and Sugeno fuzzy inference, incorporating age-adjusted ratios and cross-domain interaction features. Model performance was evaluated using standard binary classification metrics and five-fold stratified cross-validation. Results: All four assessment domains differed significantly between diagnostic groups ( Conclusion: The ANFIS approach demonstrates a clinically relevant balance between diagnostic accuracy and interpretability, positioning it as a viable clinical decision-support tool. Larger external validation studies across diverse populations are required before widespread implementation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.